Thu 2/20/2020 19:43 ET
DJIA29219.98128.570.44%TELCO191.460.130.07%GOLD1622.201.620.10%Shanghai3030.1555.751.84%
S&P 5003373.2312.820.38%BANKS502.932.260.45%OIL53.720.160.30%BITCOIN9589.7416.300.17%
NASDAQ9750.9765.330.67%PHARM615.751.540.25%US/EU1.080.000.00%Futures3363.385.720.17%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Merck - MRK   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add MRK
  
From: Raff1 (Rep: 0)Date: 10/27/2017 10:17
Forum: Merck - Msg #376Thread #673961910 (Rec: 0)
MRK 3Q Highlights
http://alph.st/b52999be

MRK reports losses in 3Q, but raises outlook. It recorded a one-time charge of $2.35 billion for a new partnership with AstraZeneca to market their existing cancer drugs and develop new ones. Keytruda sales nearly tripled in the quarter versus a year earlier, hitting $1.05 billion, and sales of hepatitis C-curing Zepatier jumped 185 percent to $468 million. Veterinary medicines brought in $1 billion, up 15 percent.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser Raff1: Reward | Watch | IgnoreMRK: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add MRK
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.